NSE filing, NSE: POLYCAB. Summary written from the filing by ALFA Finder's alert engine.
Polycab India Ltd: key numbers
- Share price
- ₹7,680.00
- Market cap
- ₹1,15,743 Cr
- Revenue (annual)
- ₹28,884 Cr
- Net profit (annual)
- ₹2,672 Cr
- P/E (TTM)
- 36.7×Sector 42.1×
- Promoter holding
- 61.44%-0.02% QoQ
- FII holding
- 18.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Polycab India Ltd
All →Polycab India Insolvency Petition
NCLAT directed MSCI not to delist Polycab from its Index pending the insolvency appeal order. The interim direction preserves index inclusion during the CIRP appeal.
Polycab India Other Announcement
Polycab India Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Polycab India Earnings Call Transcript: Key Takeaways
Polycab delivered its highest ever quarterly revenue and PAT in Q2 FY27. Performance was driven by robust 47% growth in Wires & Cables and a breakthrough 124% growth in the FMEG segment.
Polycab India Investor Presentation: Key Takeaways
Polycab delivered record performance in Q2FY27 with 53% YoY revenue growth. FMEG segment achieved historic double-digit profitability while W&C maintained strong execution momentum.
Polycab India Results Update
Polycab posted record Q2 and H1 FY27 revenue, EBITDA, and profit. Q2 revenue grew 53% YoY on strong Wires & Cables and FMEG execution.
Polycab India Q2 FY27 Results: Net Profit ₹990 Cr, Up 42.9% YoY
Polycab India Ltd reported revenue from operations of ₹9,899 Cr (+52.8% YoY) and net profit of ₹990 Cr (+42.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹990 Cr · +42.9% YoY
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.